Vaccines – Page 6
-
Podcast
Thiomersal
Kat Arney introduces the organomercury preservative associated with the current controversy around vaccines
-
News
Large HIV vaccine trial to launch in South Africa
US funding agency will enlist 5400 people for HIV vaccine study in South Africa in November
-
Business
Sanofi and Merck & Co end vaccines partnership
Two-decade-long alliance will split by end of 2016
-
Business
Mexico approves world’s first dengue vaccine
Sanofi’s vaccine protects children and adults against the mosquito-borne disease
-
News
Malaria vaccine pilot studies recommended by WHO
GlaxoSmithKline’s RTS,S vaccine must undergo further testing before being rolled out, says World Health Organization panel
-
Opinion
A shot in the arm
Vaccines for diseases that afflict the world’s poorest offer an escape not only from disease but also from poverty
-
Podcast
Chemistry World podcast – September 2015
In this months podcast, we discuss Ebola and malaria vaccines in the pipeline, the history of peer review, and managing the mountain of chemical data
-
Research
Bee immune system discovery points way to pollinator 'vaccines'
Molecular mechanism in the bee immune system could save populations in decline
-
News
Vaccine raises hopes of an end to Ebola
Trial shows vaccine provides complete protection and points way to fast-tracking medical research
-
News
Malaria vaccine approval first marred by efficacy question mark
Low protection rates in trials and uncertainty over cost-effectiveness leave vaccine’s future up in the air
-
News
Scientist imprisoned over fraudulent HIV vaccine research
Former Iowa State University researcher gets four-and-a-half years in prison for faking vaccine research funded by the NIH
-
News
Ebola vaccine shown to be safe in humans
GlaxoSmithKline vaccine will now be trialled in Liberia
-
News
Roadmap to fast track Ebola vaccine development
Expert panel recommends developing multiple vaccines and targeting at risk groups
-
News
Ebola vaccine passes first safety hurdle
Researchers hope to begin larger trials of its effectiveness in west Africa soon
-
News
US agency fast-tracks Ebola vaccine development
Health and Human Services invests almost $6 million to ready an Ebola vaccine candidate for clinical trials, meanwhile GSK says its vaccine is progressing at an ‘unprecedented rate’
-
Business
$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
News
Croatia's vaccines manufacturer left hanging as it enters administration
Lack of government investment puts national immunology institute in crisis
-
Business
GSK to apply for malaria vaccine approval
Infection protection drops over time, but the firm will go ahead with regulatory submission
-
Business
Flu vaccine without the eggs approved
Flublok does not require flu virus or eggs for manufacture